Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Teva
Cantor Fitzgerald
US Department of Justice
Moodys
Queensland Health
Baxter
Healthtrust
US Army

Generated: June 22, 2018

DrugPatentWatch Database Preview

TIGAN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for TIGAN
Pharmacology for TIGAN
Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Synonyms for TIGAN
138-56-7 (Parent)
4-(2-Dimethylaminoethoxy)-N-(3,4,5-trimethoxybenzoyl)benzylamine hydrochloride
4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride
554-92-7
554T927
AC1L29MV
AC1Q3DTA
AK140655
AKOS022172835
Ametik hydrochloride
Anaus
AX8155412
Benzamide, N-((4-(2-(dimethylamino)ethoxy)phenyl)methyl)-3,4,5-trimethoxy-, monohydrochloride
Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, hydrochloride
Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride
Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI)
Benzamide,4,5-trimethoxy-, hydrochloride
Benzamide,4,5-trimethoxy-, monohydrochloride
C-46072
C21H28N2O5.HCl
CAS-554-92-7
CCG-40276
CHEMBL1200887
CS-7696
D02733
DSSTox_CID_27754
DSSTox_GSID_47774
DSSTox_RID_82531
DTXSID7047774
EINECS 209-075-6
FT-0736653
HMS1568O21
HMS1921G21
HY-12751A
Ibikin
LS-26624
MCULE-6632962832
MLS002154193
N-({4-[2-(dimethylamino)ethoxy]phenyl}methyl)(3,4,5-trimethoxyphenyl)carboxami de, chloride
N-(4-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide hydrochloride
N-(p-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide hydrochloride
N-(p-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide monohydrochloride
N-[[4-(2-dimethylaminoethyloxy)phenyl]methyl]-3,4,5-trimethoxybenzamide hydrochloride
N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide;hydrochloride
N-[4-[2-(Dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxybenzamide Hydrochloride
N-[p-[2-(Dimethylamino)ethoxy]benzyl]-3,5-trimethoxybenzamide hydrochloride
n-{4-[2-(dim |thylamino) |thoxy]benzyl}-3,4,5-trim |thoxybenzamide chlorhydrate
Nauseton
NCGC00016509-01
NCGC00016509-06
NCGC00094803-01
NCGC00094803-02
NSC 37882
NSC-37882
NSC-757359
NSC37882
NSC757359
Pharmakon1600-01500594
Poligerim
Prestwick_526
Ro 2-9578
SBB058189
SCHEMBL41339
SMR001233483
SPECTRUM1500594
ST24048359
ST51015132
T-Gen
Tebamide
Ticon
Tox21_110465
Tox21_110465_1
Trimethobenzamide HCL
Trimethobenzamide hydrochloride
Trimethobenzamide hydrochloride (USP)
Trimethobenzamide hydrochloride [USP]
trimethobenzamide monohydrochloride
TRIMETHOBENZAMIDEHYDROCHLORIDE
UNII-WDQ5P1SX7Q
V1615
WDQ5P1SX7Q
WLN: 1OR BO1 CO1 EVM1R DO2N1&1 &GH

US Patents and Regulatory Information for TIGAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc TIGAN trimethobenzamide hydrochloride CAPSULE;ORAL 017531-006 Dec 13, 2001 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Sterile Products TIGAN trimethobenzamide hydrochloride INJECTABLE;INJECTION 017530-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Merck
Fish and Richardson
US Department of Justice
Daiichi Sankyo
Julphar
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.